Blue Sail Medical Co.,Ltd.

SZSE:002382.SZ

6.57 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 4,927.0754,900.4788,108.5867,869.4253,475.6142,653.121,575.9451,288.7711,508.9851,535.0871,335.1881,333.38933.652621.541477.703516.653405.02358.787
Cost of Revenue 4,320.9974,398.9734,301.5512,801.371,854.871,576.8171,081.133938.7711,117.5171,295.2881,146.3111,138.212838.404531.485369.191413.031346.223299.112
Gross Profit 606.078501.5043,807.0355,068.0551,620.7441,076.303494.812350391.468239.799188.877195.16895.24890.056108.512103.62158.79759.675
Gross Profit Ratio 0.1230.1020.470.6440.4660.4060.3140.2720.2590.1560.1410.1460.1020.1450.2270.2010.1450.166
Reseach & Development Expenses 290.751352.488438.523291.443197.502133.47149.72439.59318.49421.51522.32522.6367.8947.3560000
General & Administrative Expenses 134.066111.586148.03433.76358.89737.2325.46712.48323.38514.98612.55416.8479.40312.13512.11712.968.2026.12
Selling & Marketing Expenses 448.785370.592373.422439.277561.594359.5361.14850.47853.28556.40353.32844.6723.14214.84210.4511.0485.5166.862
SG&A 582.851482.177521.456473.039620.491396.7686.61562.96176.6771.38965.88261.51732.54526.97722.56624.00813.71812.982
Other Expenses -16.882193.504249.628211.403150.247-5.808-4.0483.2060.5817.78127.6712.4157.8766.8040.413-0.120.004-0.048
Operating Expenses 1,076.0711,028.1691,209.608975.885968.239673.285207.544168.721172.514151.693132.434120.09459.3144.52222.57124.00813.71812.982
Operating Income -604.846-183.8723,642.8484,017.987568.271363.725257.672216.949223.98365.17232.3762.41526.340.3180.22868.26933.73838.225
Operating Income Ratio -0.123-0.0380.4490.5110.1640.1370.1640.1680.1480.0420.0240.0470.0280.0650.1680.1320.0830.107
Total Other Income Expenses Net -152.617-221.988-2,295.49-1,999.5998.025-45.102-33.64438.7925.581-15.1833.597-10.274-1.811.573-5.3-11.52-11.337-8.516
Income Before Tax -622.61-405.861,347.3582,018.388576.296357.917253.624220.071224.53472.92360.0464.79934.12747.10680.64168.09333.74338.177
Income Before Tax Ratio -0.126-0.0830.1660.2560.1660.1350.1610.1710.1490.0480.0450.0490.0370.0760.1690.1320.0830.106
Income Tax Expense -54.25-33.544191.649255.34456.842.57951.6539.75156.37111.24913.06513.6025.0666.77220.7916.7352.8784.334
Net Income -568.36-372.3161,155.7091,758.477490.295346.714200.864181.069170.21261.70246.97451.19729.06240.33459.8561.35830.86533.843
Net Income Ratio -0.115-0.0760.1430.2230.1410.1310.1270.140.1130.040.0350.0380.0310.0650.1250.1190.0760.094
EPS -0.56-0.371.151.790.510.470.410.370.350.130.10.110.060.090.190.170.0850.093
EPS Diluted -0.57-0.371.11.730.510.470.410.370.350.130.10.110.060.090.190.170.0850.093
EBITDA 108.255305.1353,975.0134,231.696885.759583.417315.875270.255299.632160.547115.767110.43660.75466.18996.35281.56951.57847.84
EBITDA Ratio 0.0220.0620.490.5380.2550.220.20.210.1990.1050.0870.0830.0650.1060.2020.1580.1270.133